HomepageMedicineMerck Obtains Global License for Hansoh’s HS-10535 Medicine Merck Obtains Global License for Hansoh’s HS-10535 admin Posted on December 23, 2024 The molecule is an investigational pre-clinical oral GLP-1 receptor agonist. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostAsk Dr. Paola – Monday December 23, 2024 Next PostWill There Ever Be Real Size Diversity in Fashion? You Might Also Like Medicine Ensuring Global Access to LP-284 admin May 10, 2024 Medicine FDA Approves Italfarmaco SpA’s Duvyzat for Duchenne Muscular Dystrophy admin March 24, 2024 Medicine Sun Pharma and Taro Reach Definitive Merger Agreement admin January 19, 2024 Medicine FDA Accepts Resubmission of Supplemental Biologics License Application for Dupixent for Chronic Spontaneous Urticaria in Patients Under 12 admin November 16, 2024
Medicine FDA Accepts Resubmission of Supplemental Biologics License Application for Dupixent for Chronic Spontaneous Urticaria in Patients Under 12 admin November 16, 2024
